Google riding high ahead of earnings, with potential for its longest win streak in years. Japan’s election results have the Yen strengthening against the dollar. And Sarepta’s slide continues as the drug developer rebukes the FDA’s request to halt shipments of its gene therapy drug. Why one Wall Street analyst says the stock could head to zero.

Fast Money Disclaimer